Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Gilbert › NPI 1376178129
Clinic

Cleanslate Medical Group of Arizona PLLC

Cleanslate Medical Group of Arizona PLLC was paid $955K by Medicaid between Apr 2021 and Dec 2024, across 10 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 50% of everything it billed.

33Billing provider infoCLEANSLATE MEDICAL GROUP OF ARIZONA PLLC
GILBERT, AZ 85234
33aNPI1376178129assigned 03/11/2020
28Total paid$955K
24GClaims17,874
24DCodes billed10
24AFirst – last monthApr 2021 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Arizona

Rank by total paid#36 of 76
Median peer was paid$899K
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20211,408$56K
20225,973$316K
20234,334$241K
2024incomplete6,159$342K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 50% 9,004 5,233 $475K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 4,248 2,639 $249K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14% 3,168 2,335 $129K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 9.7% 944 812 $93K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 91 88 $2K
90837 Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient <1% 19 12 $2K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient <1% 42 36 $2K
81025 <1% 211 202 $1K
86803 <1% 73 70 $951.16
87340 <1% 74 74 $747.53

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMOLAREK, MATTHEW (CFO)
Same official

Other billing entities under SMOLAREK, MATTHEW

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.